BRAVO

Additional Manufacturer Narrative

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem

IT WAS REPORTED THAT A CAPSULE FAILED TO ATTACH TO THE ESOPHAGUS. THE CAPSULE WAS LOCATED IN THE ESOPHAGUS AFTER IT DID NOT ATTACH AND WAS RETRIEVED FROM THE PATIENT¿S BODY USING A SNARE. AN ADDITIONAL ATTEMPT WAS MADE TO PLACE A SECOND CAPSULE, AND THE CAPSULE WAS SUCCESSFULLY ATTACHED. NO LUBRICATION WAS USED TO FACILITATE THE PLACEMENT OF THE CAPSULE.